SummaryThe case notes and anaesthetic charts of 44 patients with dystrophic epidermolysis bullosa were reviewed retrospectively. A total qf 390 general anaesthetics were performed for 469 Key wordsComplications; dystrophic epidermolysis bullosa. Anaesthesia.Dystrophic epidermolysis bullosa (DEB) is a rare, hereditary mucocutaneous disorder whose primary feature is the formation of blisters following minor shearing trauma to the skin. Treatment of DEB involves surgery which has a number of challenging implications for the anaesthetist.In the last 30 years there have been 17 case reports of the anaesthetic management of epidermolysis bullosa (EB) but only two series (both retrospective). One looked solely at airway management during anaesthesia [I] and the other was a review of the anaesthetic management of eight patients [2].St. Thomas' Hospital (which includes the Institute of Dermatology) has been a national referral centre for EB for 15 years and so has built up a large experience of the surgical and anaesthetic management. Patients and methodsThe case notes of patients with DEB who had surgery at St. Thomas' or the Lister Hospital, London SWl , were scrutinised to determine their anaesthetic management and to record any complications that had arisen. Results PatientsFrom 1982 to January 1992, 44 patients (26 female, 18 male) with DEB had a total of 390 anaesthetics given by 20 anaesthetists. Forty patients were diagnosed as having autosomal recessive DEB and four patients had either dominant DEB or localised recessive DEB.The age range of the patients at the time of operation is shown in Figure 1. The youngest patient to have a general anaesthetic was one year old and the oldest 48 years. Surgical procedures
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.